Ventilation Devices Market Size was valued at USD 1.1 Billion in 2022. The Ventilation Devices market industry is projected to grow from USD 1.19 Billion in 2023 to USD 2.22 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.10% during the forecast period (2023 - 2032). Industrial ventilation equipment is in high demand as a result of increased industrial building. Furthermore, it is anticipated that increased air quality worries, such as poor indoor air quality, will have a significant effect on people's and workers' health. These are the key market drivers enhancing the growth of the studied market.
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
The growing demand for better air driven by the spread of Covid-19 is driving Market CAGR for Ventilation Devices. Since air filtration, ventilation, and humidity are all three essential elements employed in minimizing the risk, the demand for environmental management during the COVID-19 crisis greatly grew. Therefore, it is not advised to turn off a ventilation system in a situation like this. Filtration is a crucial component of ensuring indoor air quality (IAQ) since it lowers the risk of human infection inside the building if the virus can be caught in the filtration system itself.
Ventilation systems in homes give people a secure and cozy living space. To stop the buildup of pollutants including smoke, carbon dioxide, and volatile organic compounds, these systems control the airflow in the home. Homes should have several ventilation fans installed throughout the interior to evacuate harmful gases from within when outdoor pollution levels are high or indoor temperatures rise in the summer.
Additionally, the ventilation equipment in hospitals and clinics consumes a significant amount of energy. To ensure effective infection control and patient safety, energy usage is being reduced overall while maintaining proper ventilation and indoor air quality. Inadequate ventilation in healthcare facilities can cause airborne germs to spread throughout the building. As a result of inadequate ventilation, patients with weakened immune systems are particularly vulnerable.
In addition, people are spending more on ventilation equipment as a result of their increased concern for their health and safety. In addition to cooling residential infrastructure, supply, and exhaust ventilation also contributes to the permissible level of airborne pollutant control. Additionally, it controls temperature, humidity, and odors while also assisting in lowering heat points and stress. Thus, driving the Ventilation Devices market revenue.
The  Ventilation Devices market segmentation, based on the type, is divided into invasive, and non-invasive. The greatest segment was revealed to be the non-invasive category. During the projected period, the segment is also anticipated to grow the fastest. The use of non-invasive mechanical ventilation in a variety of applications and its capacity to deliver accurate and higher oxygen concentrations are important elements influencing the segment's growth. Modern intensive care ventilators with a variety of respiratory support modes can provide non-invasive ventilation.
Based on the product of Ventilation Devices, the  Ventilation Devices market segmentation includes High-frequency ventilation products, Long-term care (LTAC) ventilation products, Neonatal/Pediatric ventilators, and others. The category with the biggest share and the quickest projected CAGR during the projection period is high-frequency ventilation products. During the anticipated period, the market share rise for high-frequency ventilators is anticipated to be driven by the rising rates of preterm births worldwide and the breathing problems connected with early birth. As a result, there is a greater need for effective treatment choices, which is likely to drive growth in the market for high-frequency ventilators throughout the forecast period.
The Ventilation Devices market segmentation, based on end-user, includes hospitals, home care, ambulance, and clinics. The market was dominated by the hospital category. Hospitals held the majority of the revenue share. This is due to increasing hospital spending, which enables the adoption of technologically improved ventilators. Additionally, the availability of qualified healthcare professionals to operate these ventilators, the growing emphasis on better health outcomes, and enhanced hospital productivity are all fostering the segment's expansion.
Figure 1 Â Ventilation Devices Market, by End-User, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Ventilation Devises Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. During the projected period, the North American Ventilation Devices market is expected to dominate over the course of the forecasted period. The U.S. has an increasing number of COVID-19 patients who are severely ill (4,813,647 as of 3 August 2020), and prominent manufacturers are active in the area and executing production increases. To assist the government with the shortage issues of these equities equipment to mobile titans like Tesla, Ford, and GM have shifted their assembly lines for medical supplies including masks, mechanical ventilators, and other medical devices. The local market as a whole experienced tremendous growth as a result.
Further, the major countries studied in the market report are The US, Canada, German, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 Â VENTILATION DEVICES MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database, and Analyst Review
Asia Pacific Ventilation Devices market accounts for the fastest market share due to the rise of chronic respiratory disorders, rising healthcare costs, and several pandemic-related partnerships, product launches, and strategic agreements made by local players. For instance, CSIR-NAL created the Swasth Vayu non-invasive airway pressure ventilator in January 2021. Moreover, the China Ventilation Devices market held the largest market share, and the India Ventilation Devices market was the quickest-growing market in the Asia-Pacific region.
The Europe Ventilation Devices Market is expected to expand at the quickest CAGR from 2023 to 2032. This is due to the rapidly increasing housing construction activities acrosWesternrn Europe. Further, the Canada Ventilation Devices market was the fastest-growing region in the market, and the German Ventilation Devices market held a substantial share of the market.
Ventilation Devises Key Market Players & Competitive Insights
Leading market players are investing capital and resources across research and development to extend their product offerings, this is expected to help the Ventilation Devices market, grow even more. Market leaders and manufacturers are also adopting various strategies to expand their worldwide footprint, with important market developments including new product developments & launches, contracts & agreements, mergers & acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Ventilation Devices industry must offer cost-effective items.
The manufacturers are making use of locally available resources to minimize the production costs which will aid the growth of the Ventilation Devices industry to benefit clients and increase the market sector. In recent years, the Ventilation Devices industry has offered some of the most significant advantages to medicine. Major players in the Ventilation Devices Market, including Getinge AB (Sweden), E. Healthcare (U.S.), Vyaire Medical, Inc. (U.S.), Medtronic (Ireland), Drägerwerk AG & Co. KGaA (Germany), Hamilton Medical (Switzerland), Resmed (U.S.), Koninklijke Philips NV (Netherlands), Smiths Medical (U.S.), Allied Healthcare Products Inc. (U.S.), and others, are attempting to increase market demand by investing in research and development operations.
Medtronic Plc (Medtronic), originally known as Medtronic Inc., medical technology firm. It creates, develops, produces, and sells medical products. It provides products for the treatment of conditions such as heart valve issues, heart failure, aortic, peripheral vascular, venous renal, and neurological problems, as well as spine and musculoskeletal issues, ear, nose, and throat conditions. Additionally, it offers biologic solutions for the dental and orthopedic markets. Across Asia Pacific, Europe, the Americas, the Middle East, and Africa, it supplies its products & services across hospitals, healthcare providers, clinics, inclusive of governmental healthcare programs, distributors, and group purchasing organizations. The headquarters of Medtronic is in Dublin, Ireland. In October 2022, The merged Patient Monitoring and Respiratory Interventions companies ("NewCo"), which are a part of the company's Medical Surgical Portfolio, will be pursued for separation, according to Medtronic plc, a pioneer in healthcare technology.
For the diagnosis, and management of respiratory disfunctions such as sleep-disordered breathing (SDB), sleep apnea, and chronic obstructive pulmonary disease (COPD), ResMed Inc. (ResMed) designs, produces, and distributes medical equipment. Airflow generators such as CPAP machines, auto-bilevel machines, VPAP machines, APAP machines, humidifiers, and ventilation products are among its main products, along with masks, headgear, accessories, motors, diagnostic products, and data/patient management products. It also produces masks, headgear, and other protective gear. The business offers its goods to third-party payers, home healthcare providers, and sleep clinics. In the Americas, Europe, and Asia-Pacific, it conducts business through a network of fully owned subsidiaries, direct offices, and independent distributors. San Diego, California, in the US, serves as the home base for ResMed. In April 2021, ResMed announced the extension of AirView for Ventilation, a cloud-based platform for respiratory care patients' remote monitoring and management, in India.
Key Companies in the Ventilation Devices market include
Ventilation Devices Industry Developments
June 2022:The Wavin Group company Warmafloor has introduced a new line of mechanical heat recovery ventilation systems. A complete end-to-end solution is provided by the incredibly efficient Ventiza line, which aids in controlling the airflow into any home space.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.1 Billion |
| Market Size 2023 | USD 1.19 Billion |
| Market Size 2032 | USD 2.22 Billion |
| Compound Annual Growth Rate (CAGR) | 8.50% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Product, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Getinge AB (Sweden), E. Healthcare (U.S.), Vyaire Medical, Inc. (U.S.), Medtronic (Ireland), Drägerwerk AG & Co. KGaA (Germany), Hamilton Medical (Switzerland) |
| Key Market Opportunities | Growing awareness regarding good air quality |
| Key Market Dynamics | Rising elderly population and chronic diseases |
Ventilation Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Ventilation Devices market size was valued at USD 1.1 Billion in 2022.
The market is projected to grow at a CAGR of 8.10% during the forecast period, 2023-2032.
North America had the largest share of the market
The key players in the market are Getinge AB (Sweden), E. Healthcare (U.S.), Vyaire Medical, Inc. (U.S.), Medtronic (Ireland), Drägerwerk AG & Co. KGaA (Germany), Hamilton Medical (Switzerland).
The High-frequency ventilation products category dominated the market in 2022.
The non-invasive had the largest share of the market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
